Kiora Pharmaceuticals (KPRX) Tops Q2 EPS by 17c
Tweet
Share
E-mailGet Alerts KPRX Hot Sheet
Join SI Premium – FREE
Kiora Pharmaceuticals (NASDAQ: KPRX) reported Q2 EPS of ($0.34), $0.17 better than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Kiora Pharmaceuticals (KPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla readies August launch of CyberCab - The Information
- Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
- Uber, Lyft trade lower on report of August launch of Tesla's CyberCab
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
